capsid-binding antiviral
This page covers all capsid-binding antiviral drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting norovirus capsid protein.
Targets
Marketed (1)
- NAI · Glenn J. Hanna · Gastroenterology
NAI is an antiviral medication that inhibits the replication of the norovirus.
Patent intelligence
- capsid binding antiviral patent landscape — aggregated cliff calendar, attackable patents, originator estates